Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
79.52
-3.66 (-4.40%)
Nov 17, 2026, 3:00 PM CST
| Market Cap | 21.05B -24.9% |
| Revenue (ttm) | 1.75B +136.2% |
| Net Income | 568.74M |
| EPS | 2.18 |
| Shares Out | 264.71M |
| PE Ratio | 36.53 |
| Forward PE | 44.80 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,695,767 |
| Open | 83.00 |
| Previous Close | 83.18 |
| Day's Range | 79.18 - 83.00 |
| 52-Week Range | 75.10 - 160.00 |
| Beta | 0.03 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |